Dec. 7, 2012

Host: C. Kent Osborne, M.D., director of the Lester and Sue Smith Breast Cancer Center at Baylor College of Medicine, hosted a press conference featuring the following research:

• Extending Adjuvant Trastuzumab Treatment Time Provided No Additional Benefit
• Breast Cancer Genome Sequencing Identified HER2 Mutations as Targets for Drug Treatment
• Cognitive Problems May Be Present Before Chemotherapy in Women With Breast Cancer
• Adjuvant Bevacizumab Did Not Improve Invasive Disease-free Survival Rate in Triple-negative Breast Cancer
• Phase III Trial Did Not Show Superiority of Eribulin Compared With Capecitabine in Metastatic Breast Cancer

Listen to the teleconference or download* the mp3 of the teleconference (6.89 MB, 60:05 minutes)

*On a PC, right mouse click on the "download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.

Page updated: Dec. 7, 2012